{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T22:02:23Z","timestamp":1790028143383,"version":"4.0.1"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"crossref","award":["R01HL66216"],"award-info":[{"award-number":["R01HL66216"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Institutes of Health, National Institute on Aging"},{"DOI":"10.13039\/100007048","name":"Mayo Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007048","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","thrombosisresearch.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.thromres.2016.01.002","type":"journal-article","created":{"date-parts":[[2016,1,5]],"date-time":"2016-01-05T03:00:18Z","timestamp":1451962818000},"page":"29-37","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"special_numbering":"C","title":["Risk factors for incident venous thromboembolism in active cancer patients: A population based case\u2013control study"],"prefix":"10.1016","volume":"139","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6126-2528","authenticated-orcid":false,"given":"Aneel A.","family":"Ashrani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel E.","family":"Gullerud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya M.","family":"Petterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randolph S.","family":"Marks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kent R.","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Heit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.thromres.2016.01.002_bb0005","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1001\/archinte.1994.00420020066008","article-title":"Acquired risk factors for deep-vein thrombosis in symptomatic outpatients","volume":"154","author":"Cogo","year":"1994","journal-title":"Arch. Intern. Med."},{"issue":"6","key":"10.1016\/j.thromres.2016.01.002_bb0010","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1001\/archinte.160.6.809","article-title":"Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case\u2013control study","volume":"160","author":"Heit","year":"2000","journal-title":"Arch. Intern. Med."},{"issue":"2","key":"10.1016\/j.thromres.2016.01.002_bb0015","first-page":"610","article-title":"Risk factors for venous thrombotic disease","volume":"82","author":"Rosendaal","year":"1999","journal-title":"Thromb. Haemost."},{"issue":"22","key":"10.1016\/j.thromres.2016.01.002_bb0020","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1001\/archinte.160.22.3415","article-title":"An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius study","volume":"160","author":"Samama","year":"2000","journal-title":"Arch. Intern. Med."},{"issue":"6","key":"10.1016\/j.thromres.2016.01.002_bb0025","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1001\/jama.293.6.715","article-title":"Malignancies, prothrombotic mutations, and the risk of venous thrombosis","volume":"293","author":"Blom","year":"2005","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.thromres.2016.01.002_bb0030","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/sj.bjc.6605883","article-title":"Hospitalisation for venous thromboembolism in cancer patients and the general population: a population-based cohort study in Denmark, 1997\u20132006","volume":"103","author":"Cronin-Fenton","year":"2010","journal-title":"Br. J. Cancer"},{"issue":"6","key":"10.1016\/j.thromres.2016.01.002_bb0035","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/j.ejca.2012.10.021","article-title":"Incidence of venous thromboembolism in patients with cancer \u2014 a cohort study using linked United Kingdom databases","volume":"49","author":"Walker","year":"2013","journal-title":"Eur. J. Cancer"},{"issue":"11","key":"10.1016\/j.thromres.2016.01.002_bb0040","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1001\/archinte.162.11.1245","article-title":"Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study","volume":"162","author":"Heit","year":"2002","journal-title":"Arch. Intern. Med."},{"issue":"10","key":"10.1016\/j.thromres.2016.01.002_bb0045","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1093\/aje\/kwq066","article-title":"Body height and risk of venous thromboembolism: the Tromso Study","volume":"171","author":"Braekkan","year":"2010","journal-title":"Am. J. Epidemiol."},{"issue":"14","key":"10.1016\/j.thromres.2016.01.002_bb0050","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1001\/archinte.167.14.1471","article-title":"Venous thromboembolism in the outpatient setting","volume":"167","author":"Spencer","year":"2007","journal-title":"Arch. Intern. Med."},{"issue":"2","key":"10.1016\/j.thromres.2016.01.002_bb0055","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1160\/TH04-08-0506","article-title":"Effect of ethnicity and gender on the incidence of venous thromboembolism in a diverse population in California in 1996","volume":"93","author":"White","year":"2005","journal-title":"Thromb. Haemost."},{"issue":"2","key":"10.1016\/j.thromres.2016.01.002_bb0060","first-page":"128","article-title":"Cancer and thrombosis","volume":"24","author":"Donati","year":"1994","journal-title":"Haemostasis"},{"issue":"3","key":"10.1016\/j.thromres.2016.01.002_bb0065","first-page":"362","article-title":"Thrombosis and cancer","volume":"27","author":"Arkel","year":"2000","journal-title":"Semin. Oncol."},{"issue":"3","key":"10.1016\/j.thromres.2016.01.002_bb0070","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1538-7836.2007.02374.x","article-title":"Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy","volume":"5","author":"Khorana","year":"2007","journal-title":"J. Thromb. Haemost."},{"issue":"5","key":"10.1016\/j.thromres.2016.01.002_bb0075","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00005792-199909000-00001","article-title":"Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data","volume":"78","author":"Levitan","year":"1999","journal-title":"Medicine (Baltimore)"},{"issue":"17","key":"10.1016\/j.thromres.2016.01.002_bb0080","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1200\/JCO.2000.18.17.3078","article-title":"Incidence of recurrent thromboembolic and bleeding complications among patients with venous thromboembolism in relation to both malignancy and achieved international normalized ratio: a retrospective analysis","volume":"18","author":"Hutten","year":"2000","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.thromres.2016.01.002_bb0085","first-page":"805","article-title":"A comparison of the safety and efficacy of oral anticoagulation for the treatment of venous thromboembolic disease in patients with or without malignancy","volume":"84","author":"Palareti","year":"2000","journal-title":"Thromb. Haemost."},{"issue":"10","key":"10.1016\/j.thromres.2016.01.002_bb0090","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1182\/blood-2002-01-0108","article-title":"Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis","volume":"100","author":"Prandoni","year":"2002","journal-title":"Blood"},{"issue":"15","key":"10.1016\/j.thromres.2016.01.002_bb0095","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1001\/archinte.164.15.1653","article-title":"Outcomes and cost of deep venous thrombosis among patients with cancer","volume":"164","author":"Elting","year":"2004","journal-title":"Arch. Intern. Med."},{"issue":"3","key":"10.1016\/j.thromres.2016.01.002_bb0100","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s11606-006-0019-x","article-title":"The impact of venous thromboembolism on risk of death or hemorrhage in older cancer patients","volume":"22","author":"Gross","year":"2007","journal-title":"J. Gen. Intern. Med."},{"issue":"1","key":"10.1016\/j.thromres.2016.01.002_bb0105","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1160\/TH08-03-0193","article-title":"Predictive variables for major bleeding events in patients presenting with documented acute venous thromboembolism. Findings from the RIETE Registry","volume":"100","author":"Ruiz-Gimenez","year":"2008","journal-title":"Thromb. Haemost."},{"issue":"25","key":"10.1016\/j.thromres.2016.01.002_bb0110","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1056\/NEJM200012213432504","article-title":"Prognosis of cancers associated with venous thromboembolism","volume":"343","author":"Sorensen","year":"2000","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.thromres.2016.01.002_bb0115","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1001\/archinte.166.4.458","article-title":"Incidence of venous thromboembolism and its effect on survival among patients with common cancers","volume":"166","author":"Chew","year":"2006","journal-title":"Arch. Intern. Med."},{"issue":"9","key":"10.1016\/j.thromres.2016.01.002_bb0120","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1111\/j.1538-7836.2006.02082.x","article-title":"Fatal pulmonary embolism and fatal bleeding in cancer patients with venous thromboembolism: findings from the RIETE registry","volume":"4","author":"Monreal","year":"2006","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"4","key":"10.1016\/j.thromres.2016.01.002_bb0125","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2007.02450.x","article-title":"Incidence and mortality of venous thrombosis: a population-based study","volume":"5","author":"Naess","year":"2007","journal-title":"J. Thromb. Haemost."},{"issue":"5","key":"10.1016\/j.thromres.2016.01.002_bb0130","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1111\/j.1538-7836.2011.04259.x","article-title":"Prognostic relevance of an asymptomatic venous thromboembolism in patients with cancer","volume":"9","author":"Dentali","year":"2011","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"1","key":"10.1016\/j.thromres.2016.01.002_bb0135","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.thromres.2012.10.007","article-title":"Three-month mortality rate and clinical predictors in patients with venous thromboembolism and cancer. Findings from the RIETE registry","volume":"131","author":"Gussoni","year":"2013","journal-title":"Thromb. Res."},{"issue":"25","key":"10.1016\/j.thromres.2016.01.002_bb0140","doi-asserted-by":"crossref","first-page":"3972","DOI":"10.1182\/blood-2014-01-549733","article-title":"Predictors of venous thromboembolism recurrence and bleeding among active cancer patients: a population-based cohort study","volume":"123","author":"Chee","year":"2014","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.thromres.2016.01.002_bb0145","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1055\/s-0037-1613136","article-title":"Variation in relative risk of venous thromboembolism in different cancers","volume":"87","author":"Thodiyil","year":"2002","journal-title":"Thromb. Haemost."},{"issue":"4","key":"10.1016\/j.thromres.2016.01.002_bb0150","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1055\/s-0037-1613051","article-title":"Venous thrombosis in patients with solid tumors: determination of frequency and characteristics","volume":"87","author":"Sallah","year":"2002","journal-title":"Thromb. Haemost."},{"issue":"3","key":"10.1016\/j.thromres.2016.01.002_bb0155","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1538-7836.2006.01804.x","article-title":"Incidence of venous thrombosis in a large cohort of 66,329 cancer patients: results of a record linkage study","volume":"4","author":"Blom","year":"2006","journal-title":"J. Thromb. Haemost."},{"issue":"7","key":"10.1016\/j.thromres.2016.01.002_bb0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001275","article-title":"Risk of venous thromboembolism in patients with cancer: a systematic review and meta-analysis","volume":"9","author":"Horsted","year":"2012","journal-title":"PLoS Med."},{"issue":"10","key":"10.1016\/j.thromres.2016.01.002_bb0165","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1182\/blood-2013-04-460121","article-title":"Epidemiology of cancer-associated venous thrombosis","volume":"122","author":"Timp","year":"2013","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.thromres.2016.01.002_bb0170","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.thromres.2014.12.013","article-title":"Risk of site-specific cancer in incident venous thromboembolism: a population-based study","volume":"135","author":"Petterson","year":"2014","journal-title":"Thromb. Res."},{"issue":"31","key":"10.1016\/j.thromres.2016.01.002_bb0175","doi-asserted-by":"crossref","first-page":"3870","DOI":"10.1200\/JCO.2011.40.1810","article-title":"Tumor grade is associated with venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study","volume":"30","author":"Ahlbrecht","year":"2012","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.thromres.2016.01.002_bb0180","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1001\/archinte.164.2.190","article-title":"Symptomatic venous thromboembolism in cancer patients treated with chemotherapy: an underestimated phenomenon","volume":"164","author":"Otten","year":"2004","journal-title":"Arch. Intern. Med."},{"issue":"19","key":"10.1016\/j.thromres.2016.01.002_bb0185","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1001\/jama.2008.656","article-title":"Risk of venous thromboembolism with the angiogenesis inhibitor bevacizumab in cancer patients: a meta-analysis","volume":"300","author":"Nalluri","year":"2008","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.thromres.2016.01.002_bb0190","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1001\/jama.299.8.914","article-title":"Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia","volume":"299","author":"Bennett","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.thromres.2016.01.002_bb0195","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/978-0-387-79962-9_11","article-title":"Chemotherapy-associated thrombosis","volume":"148","author":"Ashrani","year":"2009","journal-title":"Cancer Treat. Res."},{"issue":"12","key":"10.1016\/j.thromres.2016.01.002_bb0200","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1002\/cncr.21496","article-title":"Risk factors for chemotherapy-associated venous thromboembolism in a prospective observational study","volume":"104","author":"Khorana","year":"2005","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.thromres.2016.01.002_bb0205","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1200\/JCO.2005.04.2150","article-title":"Venous thromboembolism in patients with colorectal cancer: incidence and effect on survival","volume":"24","author":"Alcalay","year":"2006","journal-title":"J. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.thromres.2016.01.002_bb0210","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1002\/cncr.23062","article-title":"Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients","volume":"110","author":"Khorana","year":"2007","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.thromres.2016.01.002_bb0215","doi-asserted-by":"crossref","first-page":"4902","DOI":"10.1182\/blood-2007-10-116327","article-title":"Development and validation of a predictive model for chemotherapy-associated thrombosis","volume":"111","author":"Khorana","year":"2008","journal-title":"Blood"},{"issue":"24","key":"10.1016\/j.thromres.2016.01.002_bb0220","doi-asserted-by":"crossref","first-page":"5377","DOI":"10.1182\/blood-2010-02-270116","article-title":"Prediction of venous thromboembolism in cancer patients","volume":"116","author":"Ay","year":"2010","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.thromres.2016.01.002_bb0225","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1093\/annonc\/mdr524","article-title":"Incidence, risk factors and clinical implications of venous thromboembolism in cancer patients treated within the context of phase I studies: the \u2018SENDO experience\u2019","volume":"23","author":"Mandala","year":"2012","journal-title":"Annals of Oncology"},{"issue":"3","key":"10.1016\/j.thromres.2016.01.002_bb0230","doi-asserted-by":"crossref","first-page":"266","DOI":"10.4065\/71.3.266","article-title":"History of the Rochester Epidemiology Project","volume":"71","author":"Melton","year":"1996","journal-title":"Mayo Clin. Proc."},{"issue":"6","key":"10.1016\/j.thromres.2016.01.002_bb0235","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1001\/archinte.158.6.585","article-title":"Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study","volume":"158","author":"Silverstein","year":"1998","journal-title":"Arch. Intern. Med."},{"issue":"2","key":"10.1016\/j.thromres.2016.01.002_bb0240","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1538-7836.2004.01117.x","article-title":"The incidence of venous thromboembolism among Factor V Leiden carriers: a community-based cohort study","volume":"3","author":"Heit","year":"2005","journal-title":"J. Thromb. Haemost."},{"issue":"2","key":"10.1016\/j.thromres.2016.01.002_bb0245","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.thromres.2015.06.030","article-title":"Predictors of venous thromboembolism recurrence, adjusted for treatments and interim exposures: a population-based case-cohort study","volume":"136","author":"Heit","year":"2015","journal-title":"Thromb. Res."},{"issue":"9","key":"10.1016\/j.thromres.2016.01.002_bb0250","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1161\/ATVBAHA.109.189290","article-title":"Is diabetes mellitus an independent risk factor for venous thromboembolism?: a population-based case\u2013control study","volume":"29","author":"Heit","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"5","key":"10.1016\/j.thromres.2016.01.002_bb0255","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.thromres.2010.08.010","article-title":"Is progestin an independent risk factor for incident venous thromboembolism? A population-based case\u2013control study","volume":"126","author":"Barsoum","year":"2010","journal-title":"Thromb. Res."},{"issue":"6","key":"10.1016\/j.thromres.2016.01.002_bb0260","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.thromres.2015.04.005","article-title":"Is lipid lowering therapy an independent risk factor for venous thromboembolism? A population-based case\u2013control study","volume":"136","author":"Ashrani","year":"2015","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2016.01.002_bb0265","series-title":"AJCC Cancer Staging Manual","author":"Greene","year":"2002"},{"key":"10.1016\/j.thromres.2016.01.002_bb0270","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1080\/01621459.1989.10478874","article-title":"The robust inference for the proportional hazards model","volume":"84","author":"Lin","year":"1989","journal-title":"J. Am. Stat. Assoc."},{"issue":"5","key":"10.1016\/j.thromres.2016.01.002_bb0275","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1001\/archinte.159.5.445","article-title":"Predictors of survival after deep vein thrombosis and pulmonary embolism: a population-based, cohort study","volume":"159","author":"Heit","year":"1999","journal-title":"Arch. Intern. Med."},{"issue":"8","key":"10.1016\/j.thromres.2016.01.002_bb0280","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1055\/s-0031-1297369","article-title":"Obesity and venous thrombosis: a review","volume":"37","author":"Allman-Farinelli","year":"2011","journal-title":"Semin. Thromb. Hemost."},{"issue":"6","key":"10.1016\/j.thromres.2016.01.002_bb0285","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/0002-9343(83)90805-7","article-title":"Risk factors for pulmonary embolism. The Framingham Study","volume":"74","author":"Goldhaber","year":"1983","journal-title":"Am. J. Med."},{"issue":"16","key":"10.1016\/j.thromres.2016.01.002_bb0290","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1001\/archinte.159.16.1886","article-title":"Smoking and abdominal obesity: risk factors for venous thromboembolism among middle-aged men: \u201cthe study of men born in 1913\u201d","volume":"159","author":"Hansson","year":"1999","journal-title":"Arch. Intern. Med."},{"issue":"3","key":"10.1016\/j.thromres.2016.01.002_bb0295","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1055\/s-0037-1613379","article-title":"Obesity: risk of venous thrombosis and the interaction with coagulation factor levels and oral contraceptive use","volume":"89","author":"Abdollahi","year":"2003","journal-title":"Thromb. Haemost."},{"issue":"9","key":"10.1016\/j.thromres.2016.01.002_bb0300","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.amjmed.2005.03.012","article-title":"Obesity as a risk factor in venous thromboembolism","volume":"118","author":"Stein","year":"2005","journal-title":"Am. J. Med."},{"issue":"22","key":"10.1016\/j.thromres.2016.01.002_bb0305","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1161\/01.CIR.0000131660.51520.9A","article-title":"Bidirectional relation between inflammation and coagulation","volume":"109","author":"Levi","year":"2004","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.thromres.2016.01.002_bb0310","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1093\/aje\/kwm324","article-title":"Immortal time bias in pharmaco-epidemiology","volume":"167","author":"Suissa","year":"2008","journal-title":"Am. J. Epidemiol."},{"issue":"9","key":"10.1016\/j.thromres.2016.01.002_bb0315","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1093\/aje\/kwq482","article-title":"Use of a medical records linkage system to enumerate a dynamic population over time: the Rochester epidemiology project","volume":"173","author":"St Sauver","year":"2011","journal-title":"Am. J. Epidemiol."},{"issue":"2","key":"10.1016\/j.thromres.2016.01.002_bb0320","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.mayocp.2011.11.009","article-title":"Generalizability of epidemiological findings and public health decisions: an illustration from the Rochester Epidemiology Project","volume":"87","author":"St Sauver","year":"2012","journal-title":"Mayo Clin. Proc."},{"issue":"6","key":"10.1016\/j.thromres.2016.01.002_bb0325","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1093\/ije\/dys195","article-title":"Data resource profile: the Rochester Epidemiology Project (REP) medical records-linkage system","volume":"41","author":"St Sauver","year":"2012","journal-title":"Int. J. Epidemiol."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384816300020?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384816300020?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T01:34:13Z","timestamp":1567474453000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384816300020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":65,"alternative-id":["S0049384816300020"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2016.01.002","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk factors for incident venous thromboembolism in active cancer patients: A population based case\u2013control study","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2016.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}